Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR) has a 23-report earnings history dating back to Nov 05, 2020. Its average absolute post-earnings move is ±6.08%, and 47.8% of those reactions were positive. Its largest post-earnings gain was +11.07% (Aug 03, 2023) and its largest decline was -23.98% (May 03, 2022). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
23
Avg Abs. Movement
±6.08%
Positive %
47.8%
Negative %
52.2%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | ☀ PRE | $85.39 | $85.39 | $81.07 | 689,372 | -0.54% | open_in_new |
| Feb 26, 2026 | ☀ PRE | $86.00 | $95.90 | $95.03 | 1,396,700 | +4.8% | open_in_new |
| Nov 04, 2025 | ☀ PRE | $55.80 | $61.58 | $59.91 | 830,800 | +0.32% | open_in_new |
| Aug 11, 2025 | ☀ PRE | $38.16 | $40.09 | $37.68 | 1,736,900 | -7.24% | open_in_new |
| May 09, 2025 | ☀ PRE | $33.64 | $33.64 | $30.07 | 535,900 | -2.27% | open_in_new |
| Feb 27, 2025 | ☀ PRE | $34.00 | $35.34 | $30.25 | 1,722,600 | -14.45% | open_in_new |
| Oct 31, 2024 | ☀ PRE | $44.75 | $46.98 | $46.17 | 747,800 | -3.15% | open_in_new |
| Aug 07, 2024 | ☀ PRE | $45.46 | $45.46 | $40.31 | 443,600 | -2.68% | open_in_new |
| May 02, 2024 | ☀ PRE | $36.17 | $36.83 | $36.30 | 502,700 | +0.17% | open_in_new |
| Feb 22, 2024 | ☀ PRE | $39.80 | $42.68 | $40.49 | 858,700 | +4.71% | open_in_new |
| Nov 02, 2023 | ☀ PRE | $10.09 | $12.14 | $12.08 | 1,520,900 | +4.59% | open_in_new |
| Aug 03, 2023 | ☀ PRE | $23.50 | $25.19 | $23.88 | 695,900 | +11.07% | open_in_new |
| May 04, 2023 | ☀ PRE | $28.74 | $30.35 | $26.24 | 1,396,400 | -15.08% | open_in_new |
| Feb 23, 2023 | ☀ PRE | $33.66 | $34.79 | $33.16 | 495,700 | +5.17% | open_in_new |
| Nov 03, 2022 | ☀ PRE | $29.53 | $31.87 | $30.92 | 532,200 | +7.55% | open_in_new |
| Aug 09, 2022 | ☀ PRE | $29.11 | $31.46 | $30.35 | 674,800 | -3.44% | open_in_new |
| May 03, 2022 | ☀ PRE | $29.00 | $29.11 | $24.88 | 2,228,200 | -23.98% | open_in_new |
| Feb 24, 2022 | ☀ PRE | $35.04 | $39.66 | $39.34 | 434,800 | +9.4% | open_in_new |
| Nov 10, 2021 | ☀ PRE | $65.21 | $66.03 | $63.84 | 258,400 | -2.62% | open_in_new |
| Aug 06, 2021 | ☀ PRE | $62.64 | $62.64 | $59.51 | 382,800 | -4.43% | open_in_new |
| May 06, 2021 | ☀ PRE | $41.43 | $43.00 | $40.98 | 335,100 | -0.63% | open_in_new |
| Mar 11, 2021 | ☀ PRE | $59.09 | $60.52 | $59.29 | 490,700 | +3.36% | open_in_new |
| Nov 05, 2020 | ☀ PRE | $40.99 | $45.34 | $43.71 | 111,300 | +8.09% | open_in_new |
Earnings Count
23
Total earnings in dataset
Avg Abs. Movement
±6.08%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260608 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260527 | open_in_new SEC.gov |
| 144 | 20260526 | open_in_new SEC.gov |
| 144 | 20260526 | open_in_new SEC.gov |
| 4 | 20260519 | open_in_new SEC.gov |
| 4 | 20260519 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260506 | open_in_new SEC.gov |
Frequently asked about KYMR earnings
When does Kymera Therapeutics, Inc. report earnings next? expand_more
Kymera Therapeutics, Inc. (KYMR)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does KYMR stock move after earnings? expand_more
Over 23 reports, KYMR has moved an average of ±6.08% the session after earnings, closing higher 47.8% of the time.
What was KYMR's biggest post-earnings move? expand_more
KYMR's largest post-earnings gain on record was +11.07% on Aug 03, 2023, and its largest decline was -23.98% on May 03, 2022.
Where can I find Kymera Therapeutics, Inc.'s SEC filings? expand_more
All of Kymera Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right